ORCHID PHARMA LIMITED

Inactive Instrument

Highlights Orchid Pharma Limited Bombay S.E.

Equities

524372

INE191A01019

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Orchid Pharma Gets Indian Regulator's Nod for Enmetazobactam	Jun. 06	MT
Orchid Pharma Receives DCGI Approval for Its First Invented and Made-In-India Antibiotic Drug Combination of Cefepime and Enmetazobactam	Jun. 06	CI
Orchid Pharma Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	May. 23	CI
Orchid Pharma Receives United States Food and Drug Administration Approval for Its Novel Invention	Feb. 23	CI
Orchid Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 08	CI
European Medicines Agency Grants Approval for Orchid Pharma's 'Exblifep'	Jan. 30	CI
Orchid Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 04	CI
Orchid Pharma Ties Up with GARDP to Manufacture Antibiotic for Certain Gram-Negative Infections	23-09-12	MT
Orchid Pharma Limited Enters into Manufacturing Sub License Agreement with Global Antibiotic Research & Development Partnership	23-09-12	CI
Orchid Pharma Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-10	CI
Orchid Pharma Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	23-05-10	CI
Orchid Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-02-09	CI
Orchid Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	22-11-14	CI
Reverse Split: 1 of 219.298203	19-07-24	FA
Ex-dividend day for final dividend	12-09-12	FA

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer